0:00
24:51
Anaphylaxis specialist Jay Lieberman, MD, FAAAAI, tells us everything we need to know about the first FDA approved epinephrine nasal spray to treat type 1 allergic reactions and anaphylaxis. (Participants in this podcast have disclosed a past financial relationship with the drug manufacturer.)
Weitere Episoden von „AAAAI Podcast: Conversations from the World of Allergy“
Verpasse keine Episode von “AAAAI Podcast: Conversations from the World of Allergy” und abonniere ihn in der kostenlosen GetPodcast App.